Targeting bromodomain and extra-terminal proteins reprograms macrophages and inhibits breast cancer progression
IntroductionBreast cancer (BC) remains a leading cause of cancer-related deaths, with resistance to therapy driving tumor progression. While immune checkpoint inhibitor (ICI) therapy is effective in some breast cancers, the heterogeneity of treatment r…